Immune processes included IL6/JAK/STAT3 signaling, Type I and II Interferon Responses, Toll-like Receptor signaling, and T cell receptor signaling, highlighting a more immunoreactive tumor microenvironment. The gene discussed is STAT3; the disease is neoplasm.